You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CVT

Showing 1 - 25 of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Functional Voice Disorder, Psychogenic Voice Disorder, Muscle Tension Dysphonia Trial in Ghent (ANS regulation therapy,

Recruiting
  • Functional Voice Disorder
  • +2 more
  • ANS regulation therapy
  • +2 more
  • Ghent, East-Flanders, Belgium
    Department of Rehabilitation Sciences, Ghent University (Hospita
Oct 20, 2023

Women Who Received One, Two, and Three Doses of HPV Vaccine in

Active, not recruiting
  • Human Papillomavirus Infection
  • Biospecimen Collection
  • +2 more
  • Liberia, Guanacaste, Costa Rica
    Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Aug 11, 2022

Muscle Tension Dysphonia Trial in Nottingham (Complete Vocal Technique Voice Therapy)

Recruiting
  • Muscle Tension Dysphonia
  • Complete Vocal Technique Voice Therapy
  • Nottingham, Nottinghamshire, United Kingdom
    Nottingham University Hospitals NHS Trust
May 6, 2022

Femoral Artery Stenosis, Popliteal Artery Stenosis, Femoral Artery Occlusion Trial in France, Germany (Peripheral PTA with a

Active, not recruiting
  • Femoral Artery Stenosis
  • +3 more
  • Peripheral PTA with a drug coated balloon
  • Ollioules, France
  • +7 more
Feb 15, 2023

In-stent Restenosis Trial in Worldwide (Drug Eluting Balloon)

Active, not recruiting
  • In-stent Restenosis
  • Drug Eluting Balloon
  • Grenoble, France
  • +8 more
Feb 7, 2023

Cerebral Vein Thrombosis Trial in Damascus (Rivaroxaban, Warfarin)

Completed
  • Cerebral Vein Thrombosis
  • Damascus, Damascus Governorate, Syrian Arab Republic
    Damascus University
Sep 24, 2020

The Norwegian Cerebral Venous Thrombosis Study

Recruiting
  • Cerebral Vein Thrombosis
  • Cerebral Venous Sinus Thrombosis
    • Lørenskog, Norway
      Akershus University Hospital
    Jun 6, 2022

    Direct Oral Anticoagulants for Treatment of Cerebral Venous

    Recruiting
    • Cerebral Venous Thrombosis
    • Oral anticoagulant
    • Amsterdam, Noord-Holland, Netherlands
      Jonathan Coutinho
    Feb 11, 2022

    COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis,

    Completed
    • Stroke
    • Pre-pandemic stroke related metrics
    • Stroke related metrics during the pandemic
    • Atlanta, Georgia
    • +1 more
    Nov 14, 2022

    Acute/Subacute Severe Cerebral Venous Thrombosis.

    Completed
    • Cerebral Venous Thrombosis
    • Beijing, China
      Xuanwu Hospital, Capital Medical University
    Aug 11, 2023

    Cost-effectiveness of EGDT Using FloTrac/EV1000

    Recruiting
    • Coronary Artery Disease
    • Early goal-directed therapy (EGDT)
    • Khon Kaen, Thailand
    • +1 more
    Apr 12, 2023

    Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis Trial in Weston (anonymized data

    Recruiting
    • Breast Cancer
    • +4 more
    • anonymized data collection during programmed surveillance clinical follow up
    • Weston, Florida
      Cleveland Clinic Florida
    Oct 27, 2022

    Diabetes Trial in Aurora, Chicago (Pamphlet, Video)

    Completed
    Has Results
    • Diabetes Mellitus
    • Pamphlet
    • Video
    • Aurora, Colorado
    • +2 more
    Mar 30, 2022

    National Real-world Study of Cerebral Venous Thrombosis in China

    Recruiting
    • Cerebral Vein Thrombosis
    • Cerebral Venous Sinus Thrombosis
      • Beijing, Beijing, China
        Xuan Wu Hospital，Capital Medical University
      Nov 2, 2022

      Parkinson's Disease Trial in United States (CVT-301, Sinemet)

      Completed
      • Parkinson's Disease
      • Long Beach, California
      • +4 more
      Aug 1, 2019

      New Echocardiographic Indicators in Treatment of Primary

      Not yet recruiting
      • Multiple Myeloma
      • Chemotherapy and/or autologous hematopoietic stem cell transplantation
      • (no location specified)
      Sep 18, 2023

      Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • +3 more
        • London, Ontario, Canada
          London Health Sciences Centre
        May 10, 2022

        Diabetes Foot Ulcer Trial (DiaSole)

        Not yet recruiting
        • Diabetes Mellitus Foot Ulcer
        • DiaSole
        • (no location specified)
        Oct 28, 2022

        GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating

        Active, not recruiting
        • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
          • Durham, North Carolina
            RTI Health Solutions
          Jun 14, 2022

          Stress Test in Detecting Heart Damage in Premenopausal Stage

          Completed
          • Anatomic Stage I Breast Cancer AJCC v8
          • +20 more
          • Adenosine
          • +3 more
          • Winston-Salem, North Carolina
            Wake Forest University Health Sciences
          Mar 25, 2020

          Sleep in Late Pregnancy - Artificial Intelligence Development

          Recruiting
          • Pregnancy Related
          • +4 more
          • Infrared video-audio camera
          • +3 more
          • Toronto, Ontario, Canada
            University of Toronto
          Oct 26, 2022

          Cerebral Venous Thrombosis Trial in Isfahan (Rivaroxaban, Warfarin)

          Unknown status
          • Cerebral Venous Thrombosis
          • Isfahan, Iran, Islamic Republic of
            Alzahra University Hospital
          Nov 17, 2018

          Idiopathic Parkinson's Disease Trial in Worldwide (CVT-301)

          Completed
          Has Results
          • Idiopathic Parkinson's Disease
          • Scottsdale, Arizona
          • +73 more
          Jul 30, 2019

          Class III Malocclusion, Hyoid Bone Trial in Kayseri (Skeletal Class III Malocclusion Treatment with Face Mask Group)

          Completed
          • Class III Malocclusion
          • Hyoid Bone
          • Skeletal Class III Malocclusion Treatment with Face Mask Group
          • Kayseri, Turkey
            Erciyes University Faculty of Dentistry
          Oct 29, 2021

          Recurrent Melanoma, Stage IV Skin Melanoma Trial in New York (Cisplatin, Gamma-Secretase Inhibitor RO4929097, Laboratory

          Completed
          Has Results
          • Recurrent Melanoma
          • Stage IV Skin Melanoma
          • New York, New York
            Memorial Sloan-Kettering Cancer Center
          Oct 24, 2019